Aflac Incorporated (NYSE:AFL) Holdings Lifted by Revisor Wealth Management LLC

Revisor Wealth Management LLC increased its position in shares of Aflac Incorporated (NYSE:AFL) by 66.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,273 shares of the financial services provider’s stock after acquiring an additional 2,100 shares during the period. Revisor Wealth Management LLC’s holdings in Aflac were worth $586,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Golden State Wealth Management LLC lifted its position in shares of Aflac by 121.9% during the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 167 shares during the last quarter. Garde Capital Inc. acquired a new stake in shares of Aflac during the first quarter worth $36,000. Curio Wealth LLC purchased a new stake in shares of Aflac during the fourth quarter valued at $36,000. Capital A Wealth Management LLC acquired a new position in shares of Aflac in the 4th quarter valued at $38,000. Finally, OFI Invest Asset Management acquired a new position in shares of Aflac in the 4th quarter valued at $38,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Performance

Shares of AFL stock opened at $103.51 on Thursday. Aflac Incorporated has a fifty-two week low of $88.00 and a fifty-two week high of $115.50. The stock’s 50-day moving average is $104.41 and its two-hundred day moving average is $105.21. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. The firm has a market cap of $55.96 billion, a P/E ratio of 16.17, a PEG ratio of 3.27 and a beta of 0.81.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts’ consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The company’s quarterly revenue was down 37.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.66 EPS. Analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were given a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac’s payout ratio is 36.25%.

Insider Activity

In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director owned 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the sale, the director owned 26,096 shares of the company’s stock, valued at $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,750 shares of company stock valued at $4,304,295. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on AFL shares. Keefe, Bruyette & Woods upped their price objective on shares of Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a research note on Wednesday, May 7th. Wells Fargo & Company boosted their price target on shares of Aflac from $102.00 to $103.00 and gave the company an “equal weight” rating in a report on Tuesday, May 6th. JPMorgan Chase & Co. raised their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 2nd. Morgan Stanley lifted their price objective on shares of Aflac from $100.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Monday, May 19th. Finally, Piper Sandler boosted their target price on shares of Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research note on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $106.50.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.